What does CUSIP 90400D108 represent in this 13F holders report?

CUSIP 90400D108 is the security identifier for RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK used to aggregate holder disclosures.

How many institutions held RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in Q4 2019?

162 institutional investors reported RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK for Q4 2019. Use the holders table for investor-level position and value details.

Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

CUSIP: 90400D108

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / COMMON STOCK
Shares outstanding: 98,459,627
Total 13F shares: 57,960,233
Share change: -714,079
Total reported value: $2,475,997,749
Put/Call ratio: 666%
Price per share: $42.71
Number of holders: 162
Value change: -$30,518,994
Number of buys: 86
Number of sells: 69

Quarterly Holders Quick Answers

What is CUSIP 90400D108?
CUSIP 90400D108 identifies RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 90400D108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Capital Research Global Investors	13F	Company	6.5%	6,357,181	$271,960,000	—	30 Sep 2019	13F
Capital International Investors	13F	Company	6.1%	6,008,757	$257,055,000	—	30 Sep 2019	13F
VANGUARD GROUP INC	13F	Company	5.2%	5,072,925	$217,020,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	4.7%	4,625,207	$197,868,000	—	30 Sep 2019	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.5%	4,455,585	$190,610,000	—	30 Sep 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	3.3%	3,259,962	$139,462,000	—	30 Sep 2019	13F
FEDERATED HERMES, INC.	13F	Company	2.9%	2,854,310	$122,108,000	—	30 Sep 2019	13F
Capital World Investors	13F	Company	2.4%	2,371,430	$101,450,000	—	30 Sep 2019	13F
STATE STREET CORP	13F	Company	2.1%	2,110,888	$90,304,000	—	30 Sep 2019	13F
FMR LLC	13F	Company	2.1%	2,083,621	$89,137,000	—	30 Sep 2019	13F
ALKEON CAPITAL MANAGEMENT LLC	13F	Company	1.6%	1,586,733	$67,880,000	—	30 Sep 2019	13F
Clearbridge Investments, LLC	13F	Company	1.4%	1,381,777	$59,112,000	—	30 Sep 2019	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	1.4%	1,335,758	$57,144,000	—	30 Sep 2019	13F
MACQUARIE GROUP LTD	13F	Company	1.3%	1,236,013	$52,877,000	—	30 Sep 2019	13F
FIRST TRUST ADVISORS LP	13F	Company	1%	999,166	$42,744,000	—	30 Sep 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.92%	901,828	$38,580,000	—	30 Sep 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.85%	834,313	$35,692,000	—	30 Sep 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.74%	731,679	$31,301,000	—	30 Sep 2019	13F
NORTHERN TRUST CORP	13F	Company	0.74%	724,177	$30,981,000	—	30 Sep 2019	13F
Rock Springs Capital Management LP	13F	Company	0.62%	608,000	$26,010,000	—	30 Sep 2019	13F
NORGES BANK	13F	Company	0.52%	512,564	$21,928,000	—	30 Sep 2019	13F
Capital International, Inc./CA/	13F	Company	0.48%	471,065	$20,152,000	—	30 Sep 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.47%	462,377	$19,778,000	—	30 Sep 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.45%	438,746	$18,770,000	—	30 Sep 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.4%	395,924	$16,937,000	—	30 Sep 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	329,693	$14,105,000	—	30 Sep 2019	13F
AXA S.A.	13F	Company	0.33%	329,355	$14,090,000	—	30 Sep 2019	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.32%	315,968	$13,517,000	—	30 Sep 2019	13F
HIGHLINE CAPITAL MANAGEMENT, L.P.	13F	Company	0.3%	295,653	$12,648,000	—	30 Sep 2019	13F
Nuveen Asset Management, LLC	13F	Company	0.28%	273,386	$11,695,000	—	30 Sep 2019	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.27%	267,834	$11,458,000	—	30 Sep 2019	13F
LOOMIS SAYLES & CO L P	13F	Company	0.24%	238,194	$10,190,000	—	30 Sep 2019	13F
Bank of New York Mellon Corp	13F	Company	0.23%	226,246	$9,679,000	—	30 Sep 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.19%	188,383	$8,059,000	—	30 Sep 2019	13F
First Light Asset Management, LLC	13F	Company	0.18%	179,659	$7,686,000	—	30 Sep 2019	13F
Gamma As Sector	13F	Individual	0.18%	172,978	$7,400,000	—	30 Sep 2019	13F
UBS Group AG	13F	Company	0.17%	164,248	$7,027,000	—	30 Sep 2019	13F
Hudson Bay Capital Management LP	13F	Company	0.16%	155,000	$6,631,000	—	30 Sep 2019	13F
FRANKLIN RESOURCES INC	13F	Company	0.15%	145,450	$6,222,000	—	30 Sep 2019	13F
S.c.a. Candriam	13F	Individual	0.14%	140,500	$6,011,000	—	30 Sep 2019	13F
MORGAN STANLEY	13F	Company	0.14%	139,660	$5,973,000	—	30 Sep 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.14%	138,822	$5,938,000	—	30 Sep 2019	13F
Capital Bank & Trust Co	13F	Company	0.13%	128,700	$5,506,000	—	30 Sep 2019	13F
FRED ALGER MANAGEMENT, LLC	13F	Company	0.12%	120,264	$5,145,000	—	30 Sep 2019	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.12%	113,815	$4,869,000	—	30 Sep 2019	13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.	13F	Company	0.11%	107,590	$4,603,000	—	30 Sep 2019	13F
Swiss National Bank	13F	Company	0.1%	102,852	$4,400,000	—	30 Sep 2019	13F
Rafferty Asset Management, LLC	13F	Company	0.1%	98,807	$4,227,000	—	30 Sep 2019	13F
Tekla Capital Management LLC	13F	Company	0.1%	97,480	$4,170,000	—	30 Sep 2019	13F
Erste Asset Management GmbH	13F	Company	0.1%	95,310	$4,064,675	—	30 Sep 2019	13F

Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q4 2019

As of 31 Dec 2019, Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) was held by 162 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,960,233 shares. The largest 10 holders included Capital Research Global Investors, Capital International Investors, VANGUARD GROUP INC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, Capital World Investors, FEDERATED HERMES, INC., STATE STREET CORP, FMR LLC, and ALLIANCEBERNSTEIN L.P.. This page lists 162 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

164

Q4 2019 holders

162

Holder diff

-2

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.